76 related articles for article (PubMed ID: 16472475)
1. Influence of the dialysis membrane on markers of tissue ischemia.
Carrega L; Giaime P; Montserrat C; Vincente O; Brunet P; Dussol B; Berland Y; Guieu R
J Investig Med; 2006 Mar; 54(2):62-6. PubMed ID: 16472475
[TBL] [Abstract][Full Text] [Related]
2. Adenosine and hemodialysis in humans.
Guieu R; Brunet P; Sampol J; Bechis G; Fenouillet E; Mege JL; Capo C; Vitte J; Ibrahim Z; Carrega L; Lerda D; Rochat H; Berland Y; Dussol B
J Investig Med; 2001 Jan; 49(1):56-67. PubMed ID: 11217148
[TBL] [Abstract][Full Text] [Related]
3. Differences in ischemia-modified albumin levels between end stage renal disease patients and the normal population.
Turedi S; Cinar O; Yavuz I; Mentese A; Gunduz A; Karahan SC; Topbas M; Cevik E; Yildirim AO; Uzun A; Kaldirim U
J Nephrol; 2010; 23(3):335-40. PubMed ID: 20349416
[TBL] [Abstract][Full Text] [Related]
4. Ischemia modified albumin and carbonyl protein as potential biomarkers of protein oxidation in hemodialysis.
Albarello K; dos Santos GA; Bochi GV; Sangoi MB; Almeida TC; Paz da Silva JE; Garcia SC; Moresco RN
Clin Biochem; 2012 Apr; 45(6):450-4. PubMed ID: 22342921
[TBL] [Abstract][Full Text] [Related]
5. Impact of the type of dialysis membranes on the circulating concentration of markers of vitamin D metabolism.
Cavalier E; Torres PU; Dubois BE; Smelten N; Pottel H; Krzesinski JM; Delanaye P
Int J Artif Organs; 2017 Mar; 40(2):43-47. PubMed ID: 28222207
[TBL] [Abstract][Full Text] [Related]
6. 8-hydroxy-2'-deoxyguanosine of leukocyte DNA as a marker of oxidative stress in chronic hemodialysis patients.
Tarng DC; Huang TP; Wei YH; Liu TY; Chen HW; Wen Chen T; Yang WC
Am J Kidney Dis; 2000 Nov; 36(5):934-44. PubMed ID: 11054349
[TBL] [Abstract][Full Text] [Related]
7. Maternal serum ischemia-modified albumin: a biomarker to distinguish between normal pregnancy and preeclampsia?
Gafsou B; Lefèvre G; Hennache B; Houfflin Debarge V; Ducloy-Bouthors AS
Hypertens Pregnancy; 2010 Jan; 29(1):101-11. PubMed ID: 20132025
[TBL] [Abstract][Full Text] [Related]
8. High adenosine and deoxyadenosine concentrations in mononuclear cells of hemodialyzed patients.
Sampol J; Dussol B; Fenouillet E; Capo C; Mege JL; Halimi G; Bechis G; Brunet P; Rochat H; Berland Y; Guieu R
J Am Soc Nephrol; 2001 Aug; 12(8):1721-1728. PubMed ID: 11461945
[TBL] [Abstract][Full Text] [Related]
9. Ischemia-modified albumin, a predictive marker of major adverse cardiovascular events in continuous ambulatory peritoneal dialysis patients.
Su X; Zhang K; Guo F; Yuan B; Wang C; Xiao L; Wang J; Huang H
Clin Biochem; 2013 Oct; 46(15):1410-3. PubMed ID: 23796881
[TBL] [Abstract][Full Text] [Related]
10. Precedent fluctuation of serum hs-CRP to albumin ratios and mortality risk of clinically stable hemodialysis patients.
Hwang JC; Jiang MY; Lu YH; Wang CT
PLoS One; 2015; 10(3):e0120266. PubMed ID: 25793462
[TBL] [Abstract][Full Text] [Related]
11. Ischemia-modified albumin levels in patients with end-stage renal disease patients on hemodialysis: does albumin analysis method affect albumin-adjusted ischemia-modified albumin levels?
Kiyici A; Mehmetoğlu I; Karaoğlan H; Atalay H; Solak Y; Türk S
J Clin Lab Anal; 2010; 24(4):273-7. PubMed ID: 20626021
[TBL] [Abstract][Full Text] [Related]
12. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
Lovcić V; Kes P; Zeljko R; Kusec V
Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
[TBL] [Abstract][Full Text] [Related]
13. Ischemia-modified albumin levels in cord blood: a case-control study in uncomplicated and complicated deliveries.
Gugliucci A; Hermo R; Monroy C; Numaguchi M; Kimura S
Clin Chim Acta; 2005 Dec; 362(1-2):155-60. PubMed ID: 16018994
[TBL] [Abstract][Full Text] [Related]
14. Biocompatible dialysis membranes and oxidative stress in patients wih end-stage renal disease on maintenance haemodialysis.
Abdel-Naeem NM; Kandell NF; El-Shamaa AA; Harba TM; Abdel-Hady AA
J Egypt Soc Parasitol; 2005 Dec; 35(3 Suppl):1173-97. PubMed ID: 16363293
[TBL] [Abstract][Full Text] [Related]
15. Is dialysis membrane type responsible for increased circulating adhesion molecules during chronic hemodialysis?
Mrowka C; Heintz B; Sieberth HG
Clin Nephrol; 1999 Nov; 52(5):312-21. PubMed ID: 10584995
[TBL] [Abstract][Full Text] [Related]
16. Effect of vitamin E-bonded membrane on the 8-hydroxy 2'-deoxyguanosine level in leukocyte DNA of hemodialysis patients.
Tarng DC; Huang TP; Liu TY; Chen HW; Sung YJ; Wei YH
Kidney Int; 2000 Aug; 58(2):790-9. PubMed ID: 10916104
[TBL] [Abstract][Full Text] [Related]
17. Kinetic study of adenosine concentrations and the expression of adenosine deaminase in mononuclear cells during hemodialysis.
Dussol B; Fenouillet E; Brunet P; Purgus R; Sauze N; Carrega L; Mercier L; Zouher I; Bechis G; Berland Y; Guieu R
Kidney Int; 2004 Oct; 66(4):1640-6. PubMed ID: 15458461
[TBL] [Abstract][Full Text] [Related]
18. Influence of haemodialysis and left ventricular failure on peripheral A(2A) adenosine receptor expression.
Carrega L; Fenouillet E; Giaime P; Charavil A; Mercier L; Gerolami V; Berge-Lefranc JL; Berland Y; Ruf J; Saadjian A; Dussol B; Guieu R
Nephrol Dial Transplant; 2007 Mar; 22(3):851-6. PubMed ID: 17132707
[TBL] [Abstract][Full Text] [Related]
19. [Late nephrology referral influences on morbidity and mortality of hemodialysis patients. A provincial study].
Peña JM; Logroño JM; Pernaute R; Laviades C; Virto R; Vicente de Vera C
Nefrologia; 2006; 26(1):84-97. PubMed ID: 16649429
[TBL] [Abstract][Full Text] [Related]
20. Assessment of Ischemia Modified Albumin as a Marker of Oxidative Stress in Chronic Kidney Disease.
Ozkurt S; Ozcan O; Dogan I
Saudi J Kidney Dis Transpl; 2021; 32(4):1006-1012. PubMed ID: 35229799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
